_id

690db452ccc777a4e85d0d44

Ticker

AYTU

Name

Aytu BioScience Inc

Exchange

NASDAQ

Address

Denver Corporate Center III, Denver, CO, United States, 80237

Country

USA

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Currency

USD

Website

https://aytubio.com

Description

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.

Last Close

2.28

Volume

28381

Current Price

2.28

Change

0

Last Updated

2025-11-28T12:39:07.536Z

Image

data:image/webp;base64,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

Ipo Date

2017-02-01T00:00:00.000Z

Market Cap

21395236

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.6452714285714286

Sentiment Sources

7

Rating

4

Target Price

9.1667

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

13888000

Cost Of Revenue

4702000

Gross Profit

9186000

Operating Expenses

10690000

Operating Income

-1504000

Interest Expense

516000

Pretax Income

1965000

Net Income

1965000

Eps

0.10089011782579485

Dividends Per Share

-

Shares Outstanding

10188208

Income Tax Expense

-

EBITDA

3284000

Operating Margin

-10.829493087557603

Total Other Income Expense Net

3469000

Cash

32630000

Short Term Investments

-

Receivables

33225000

Inventories

10100000

Total Current Assets

81109000

Property Plant Equipment

1510000

Total Assets

124988000

Payables

12342000

Short Term Debt

1857000

Long Term Debt

10447000

Total Liabilities

101817000

Equity

23171000

Depreciation

803000

Change In Working Capital

-23000

Cash From Operations

-618000

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

2296000

Net Change In Cash

1678000

PE

-

PB

1.9164786931940787

ROE

8.480428121358594

ROA

1.5721509264889428

FCF

-618000

Fcf Percent

-0.04449884792626728

Piotroski FScore

2

Health Score

39

Deep Value Investing Score

6

Defensive Investing Score

5.5

Dividend Investing Score

1.5

Economic Moat Investing Score

5.3

Garp Investing Score

1

Growth Investing Score

1

Momentum Investing Score

4

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

6.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

13888000

Quarters > 0 > income Statement > cost Of Revenue

4702000

Quarters > 0 > income Statement > gross Profit

9186000

Quarters > 0 > income Statement > operating Expenses

10690000

Quarters > 0 > income Statement > operating Income

-1504000

Quarters > 0 > income Statement > interest Expense

516000

Quarters > 0 > income Statement > pretax Income

1965000

Quarters > 0 > income Statement > net Income

1965000

Quarters > 0 > income Statement > eps

0.10089011782579485

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

19476635

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

3284000

Quarters > 0 > income Statement > operating Margin

-10.829493087557603

Quarters > 0 > income Statement > total Other Income Expense Net

3469000

Quarters > 0 > balance Sheet > cash

32630000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

33225000

Quarters > 0 > balance Sheet > inventories

10100000

Quarters > 0 > balance Sheet > total Current Assets

81109000

Quarters > 0 > balance Sheet > property Plant Equipment

1510000

Quarters > 0 > balance Sheet > total Assets

124988000

Quarters > 0 > balance Sheet > payables

12342000

Quarters > 0 > balance Sheet > short Term Debt

1857000

Quarters > 0 > balance Sheet > long Term Debt

10447000

Quarters > 0 > balance Sheet > total Liabilities

101817000

Quarters > 0 > balance Sheet > equity

23171000

Quarters > 0 > cash Flow > net Income

1965000

Quarters > 0 > cash Flow > depreciation

803000

Quarters > 0 > cash Flow > change In Working Capital

-23000

Quarters > 0 > cash Flow > cash From Operations

-618000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

2296000

Quarters > 0 > cash Flow > net Change In Cash

1678000

Quarters > 0 > ratios > PE

0.10089011782579485

Quarters > 0 > ratios > PB

1.9164786931940787

Quarters > 0 > ratios > ROE

8.480428121358594

Quarters > 0 > ratios > ROA

1.5721509264889428

Quarters > 0 > ratios > FCF

-618000

Quarters > 0 > ratios > Piotroski FScore

2

Quarters > 0 > ratios > fcf Percent

-0.04449884792626728

Quarters > 0 > health Score

39

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

15135000

Quarters > 1 > income Statement > cost Of Revenue

4881000

Quarters > 1 > income Statement > gross Profit

10254000

Quarters > 1 > income Statement > operating Expenses

17877000

Quarters > 1 > income Statement > operating Income

-7623000

Quarters > 1 > income Statement > interest Expense

730000

Quarters > 1 > income Statement > pretax Income

-19443000

Quarters > 1 > income Statement > net Income

-19818000

Quarters > 1 > income Statement > eps

-2.918045589713779

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

6791532

Quarters > 1 > income Statement > income Tax Expense

437000

Quarters > 1 > income Statement > EBITDA

-17419000

Quarters > 1 > income Statement > operating Margin

-50.36669970267592

Quarters > 1 > income Statement > total Other Income Expense Net

-11820000

Quarters > 1 > balance Sheet > cash

30952000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

31155000

Quarters > 1 > balance Sheet > inventories

11434000

Quarters > 1 > balance Sheet > total Current Assets

79179000

Quarters > 1 > balance Sheet > property Plant Equipment

1593000

Quarters > 1 > balance Sheet > total Assets

124177000

Quarters > 1 > balance Sheet > payables

10601000

Quarters > 1 > balance Sheet > short Term Debt

11057000

Quarters > 1 > balance Sheet > long Term Debt

10895000

Quarters > 1 > balance Sheet > total Liabilities

105211000

Quarters > 1 > balance Sheet > equity

18966000

Quarters > 1 > cash Flow > net Income

-19880000

Quarters > 1 > cash Flow > depreciation

1294000

Quarters > 1 > cash Flow > change In Working Capital

1641000

Quarters > 1 > cash Flow > cash From Operations

2803000

Quarters > 1 > cash Flow > capital Expenditures

17000

Quarters > 1 > cash Flow > cash From Investing

-3017000

Quarters > 1 > cash Flow > cash From Financing

12993000

Quarters > 1 > cash Flow > net Change In Cash

12779000

Quarters > 1 > ratios > PE

-2.918045589713779

Quarters > 1 > ratios > PB

0.8164448465675418

Quarters > 1 > ratios > ROE

-104.49224928819993

Quarters > 1 > ratios > ROA

-15.95947719787078

Quarters > 1 > ratios > FCF

2786000

Quarters > 1 > ratios > Piotroski FScore

2

Quarters > 1 > ratios > fcf Percent

0.1840766435414602

Quarters > 1 > health Score

33

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

18452000

Quarters > 2 > income Statement > cost Of Revenue

5646000

Quarters > 2 > income Statement > gross Profit

12806000

Quarters > 2 > income Statement > operating Expenses

10385000

Quarters > 2 > income Statement > operating Income

2421000

Quarters > 2 > income Statement > interest Expense

900000

Quarters > 2 > income Statement > pretax Income

3818000

Quarters > 2 > income Statement > net Income

3994000

Quarters > 2 > income Statement > eps

0.48680880980121405

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

8204453

Quarters > 2 > income Statement > income Tax Expense

-122000

Quarters > 2 > income Statement > EBITDA

6035000

Quarters > 2 > income Statement > operating Margin

13.120528939952308

Quarters > 2 > income Statement > total Other Income Expense Net

1397000

Quarters > 2 > balance Sheet > cash

18173000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

35825000

Quarters > 2 > balance Sheet > inventories

11058000

Quarters > 2 > balance Sheet > total Current Assets

72512000

Quarters > 2 > balance Sheet > property Plant Equipment

1657000

Quarters > 2 > balance Sheet > total Assets

124201000

Quarters > 2 > balance Sheet > payables

12041000

Quarters > 2 > balance Sheet > short Term Debt

11987000

Quarters > 2 > balance Sheet > long Term Debt

9535000

Quarters > 2 > balance Sheet > total Liabilities

89303000

Quarters > 2 > balance Sheet > equity

34898000

Quarters > 2 > cash Flow > net Income

3994000

Quarters > 2 > cash Flow > depreciation

1483000

Quarters > 2 > cash Flow > change In Working Capital

-9758000

Quarters > 2 > cash Flow > cash From Operations

-6455000

Quarters > 2 > cash Flow > capital Expenditures

69000

Quarters > 2 > cash Flow > cash From Investing

-69000

Quarters > 2 > cash Flow > cash From Financing

4299000

Quarters > 2 > cash Flow > net Change In Cash

-2225000

Quarters > 2 > ratios > PE

0.48680880980121405

Quarters > 2 > ratios > PB

0.5360236357384377

Quarters > 2 > ratios > ROE

11.44478193592756

Quarters > 2 > ratios > ROA

3.215755106641653

Quarters > 2 > ratios > FCF

-6524000

Quarters > 2 > ratios > Piotroski FScore

2

Quarters > 2 > ratios > fcf Percent

-0.3535660091047041

Quarters > 2 > health Score

46

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

16221000

Quarters > 3 > income Statement > cost Of Revenue

5435000

Quarters > 3 > income Statement > gross Profit

10786000

Quarters > 3 > income Statement > operating Expenses

12481000

Quarters > 3 > income Statement > operating Income

-1695000

Quarters > 3 > income Statement > interest Expense

1079000

Quarters > 3 > income Statement > pretax Income

382000

Quarters > 3 > income Statement > net Income

788000

Quarters > 3 > income Statement > eps

0.09286854433978008

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

8485112

Quarters > 3 > income Statement > income Tax Expense

-283000

Quarters > 3 > income Statement > EBITDA

2634000

Quarters > 3 > income Statement > operating Margin

-10.449417421860552

Quarters > 3 > income Statement > total Other Income Expense Net

2077000

Quarters > 3 > balance Sheet > cash

20398000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

25403000

Quarters > 3 > balance Sheet > inventories

11085000

Quarters > 3 > balance Sheet > total Current Assets

63053000

Quarters > 3 > balance Sheet > property Plant Equipment

1694000

Quarters > 3 > balance Sheet > total Assets

116227000

Quarters > 3 > balance Sheet > payables

11699000

Quarters > 3 > balance Sheet > short Term Debt

6051000

Quarters > 3 > balance Sheet > long Term Debt

9983000

Quarters > 3 > balance Sheet > total Liabilities

85462000

Quarters > 3 > balance Sheet > equity

30765000

Quarters > 3 > cash Flow > net Income

788000

Quarters > 3 > cash Flow > depreciation

1173000

Quarters > 3 > cash Flow > change In Working Capital

3238000

Quarters > 3 > cash Flow > cash From Operations

2905000

Quarters > 3 > cash Flow > capital Expenditures

6000

Quarters > 3 > cash Flow > cash From Investing

145000

Quarters > 3 > cash Flow > cash From Financing

-2760000

Quarters > 3 > cash Flow > net Change In Cash

290000

Quarters > 3 > ratios > PE

0.09286854433978008

Quarters > 3 > ratios > PB

0.6288332637737688

Quarters > 3 > ratios > ROE

2.5613521859255646

Quarters > 3 > ratios > ROA

0.6779836010565531

Quarters > 3 > ratios > FCF

2899000

Quarters > 3 > ratios > Piotroski FScore

4

Quarters > 3 > ratios > fcf Percent

0.17871894457801615

Quarters > 3 > health Score

55

Valuation > metrics > PE

0.10089011782579485

Valuation > metrics > PB

1.9164786931940787

Valuation > final Score

100

Valuation > verdict

49.5% Undervalued

Profitability > metrics > ROE

8.480428121358594

Profitability > metrics > ROA

2.4226657954111137

Profitability > metrics > Net Margin

0.14148905529953917

Profitability > final Score

45

Profitability > verdict

Weak

Risk > metrics > Debt Equity

4.394156488714342

Risk > metrics > Interest Coverage

-2.9147286821705425

Risk > final Score

-6

Risk > verdict

High

Liquidity > metrics > Current Ratio

5.712303683357983

Liquidity > metrics > Quick Ratio

5.0009859849285165

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

90

Prev Valuations > 2

90

Prev Profitabilities > 0

0

Prev Profitabilities > 1

69

Prev Profitabilities > 2

16

Prev Risks > 0

-36

Prev Risks > 1

29

Prev Risks > 2

12

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-13T00:27:16.178Z